Product Code: ETC6190549 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Although next-generation sequencing (NGS) is becoming more widespread, Sanger sequencing remains a cornerstone of DNA analysis in Australia for specific applications such as validation of NGS results and smaller-scale genetic studies. The market is supported by academic institutions, diagnostic laboratories, and agricultural genomics sectors. Continued use in clinical diagnostics, especially in inherited diseases and cancer genetics, sustains the demand for reliable and accurate sequencing methods.
Sanger sequencing remains relevant in Australia for applications requiring high accuracy, such as validation of next-generation sequencing (NGS) results and targeted gene sequencing. The market is witnessing stable demand in academic, clinical, and forensic sectors. While NGS dominates large-scale sequencing, Sanger technology is evolving through automation, faster protocols, and integration into hybrid sequencing workflows.
The Sanger sequencing market in Australia is under pressure from newer next-generation sequencing (NGS) technologies that offer higher throughput and cost efficiency. Declining demand for traditional Sanger methods is leading to reduced investment and innovation in the field. In addition, a shortage of skilled personnel, high equipment maintenance costs, and stringent data storage regulations further constrain the markets ability to remain competitive.
Despite the dominance of NGS, Sanger sequencing still presents viable investment paths in clinical diagnostics, validation services, and forensics. There is potential in offering fast-turnaround sequencing services and lab automation solutions. Diagnostic labs and academic institutions in Australia rely on high-accuracy sequencing platforms, creating opportunities for suppliers of updated instrumentation and consumables that streamline Sanger workflows.
Government policies affecting the Sanger sequencing market in Australia largely focus on health and research funding. Policies provide support for genomic research, and there are significant investments in national health strategies aimed at integrating genomics into clinical practice. However, the market faces competition from next-generation sequencing technologies, which are favored by government policies focused on reducing healthcare costs and improving diagnostic capabilities. Regulatory standards for genetic testing and data privacy policies also shape the way Sanger sequencing technologies are utilized in healthcare.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Sanger Sequencing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Sanger Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Sanger Sequencing Market - Industry Life Cycle |
3.4 Australia Sanger Sequencing Market - Porter's Five Forces |
3.5 Australia Sanger Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Australia Sanger Sequencing Market Revenues & Volume Share, By Sequencing, 2021 & 2031F |
3.7 Australia Sanger Sequencing Market Revenues & Volume Share, By Laboratory, 2021 & 2031F |
3.8 Australia Sanger Sequencing Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Australia Sanger Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Sanger Sequencing Market Trends |
6 Australia Sanger Sequencing Market, By Types |
6.1 Australia Sanger Sequencing Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Australia Sanger Sequencing Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Australia Sanger Sequencing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 Australia Sanger Sequencing Market Revenues & Volume, By Biomarkers and Cancer, 2021- 2031F |
6.1.5 Australia Sanger Sequencing Market Revenues & Volume, By Reproductive Health, 2021- 2031F |
6.1.6 Australia Sanger Sequencing Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.1.7 Australia Sanger Sequencing Market Revenues & Volume, By Forensics, 2021- 2031F |
6.1.8 Australia Sanger Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Sanger Sequencing Market, By Sequencing |
6.2.1 Overview and Analysis |
6.2.2 Australia Sanger Sequencing Market Revenues & Volume, By Shotgun Sequencing, 2021- 2031F |
6.2.3 Australia Sanger Sequencing Market Revenues & Volume, By Targeted Gene Sequencing, 2021- 2031F |
6.2.4 Australia Sanger Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Sanger Sequencing Market, By Laboratory |
6.3.1 Overview and Analysis |
6.3.2 Australia Sanger Sequencing Market Revenues & Volume, By Wet Labs, 2021- 2031F |
6.3.3 Australia Sanger Sequencing Market Revenues & Volume, By Dry Labs, 2021- 2031F |
6.4 Australia Sanger Sequencing Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Australia Sanger Sequencing Market Revenues & Volume, By Academic, 2021- 2031F |
6.4.3 Australia Sanger Sequencing Market Revenues & Volume, By Government Research Institutes, 2021- 2031F |
6.4.4 Australia Sanger Sequencing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.5 Australia Sanger Sequencing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.4.6 Australia Sanger Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.7 Australia Sanger Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Australia Sanger Sequencing Market Import-Export Trade Statistics |
7.1 Australia Sanger Sequencing Market Export to Major Countries |
7.2 Australia Sanger Sequencing Market Imports from Major Countries |
8 Australia Sanger Sequencing Market Key Performance Indicators |
9 Australia Sanger Sequencing Market - Opportunity Assessment |
9.1 Australia Sanger Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Australia Sanger Sequencing Market Opportunity Assessment, By Sequencing, 2021 & 2031F |
9.3 Australia Sanger Sequencing Market Opportunity Assessment, By Laboratory, 2021 & 2031F |
9.4 Australia Sanger Sequencing Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Australia Sanger Sequencing Market - Competitive Landscape |
10.1 Australia Sanger Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Australia Sanger Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |